Predictors of health status do not change over three-year periods and exacerbation makes difference in chronic obstructive pulmonary disease

Health and Quality of Life Outcomes

Volumn 9, Issue , 2011, Pages

  Ferrari, Renata ^a   Tanni, Suzana E ^a   Caram, Laura M O ^a   Naves, Cristiane R ^a   Godoy, Irma ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Bode index; Copd; Dyspnea; Health status

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID;

AGED; ARTICLE; BODE INDEX; BODY COMPOSITION; CHARLSON COMORBIDITY INDEX; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MODIFIED MEDICAL RESEARCH COUNCIL DYSPNEA SCALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PREDICTION; PULSE OXIMETRY; RATING SCALE; SAINT GEORGE RESPIRATORY QUESTIONNAIRE; SIX MINUTE WALK DISTANCE; WALKING; AGE; COMORBIDITY; DISEASE COURSE; HOSPITALIZATION; LUNG FUNCTION TEST; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROSPECTIVE STUDY; QUESTIONNAIRE; REGRESSION ANALYSIS; SEX DIFFERENCE; SMOKING;

AGE FACTORS; AGED; COMORBIDITY; DISEASE PROGRESSION; FEMALE; HEALTH STATUS; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; REGRESSION ANALYSIS; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SMOKING; STATISTICS, NONPARAMETRIC;

EID: 83055192058     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-9-112     Document Type: Article

References (41)

1. Global Initiative for Chronic Obstructive Lung Disease Global Strategy for the diagnosis, management, and prevention of COPD (update 2010). Accessed on http://www.goldcopd.com, on March 15, 2011, Global Initiative for Chronic Obstructive Lung Disease.
2. Jones PW. Health status and the spiral of decline. COPD 2009, 6:59-63. 10.1080/15412550802587943, 19229709.
3. Jones PW. Health status measurement in chronic obstructive pulmonary disease. Thorax 2001, 56:880-887. Review, 10.1136/thorax.56.11.880, 1745959, 11641515.
4. Spencer S, Calverley PMA, Burge PS, Jones PW. Health status deterioration in patients with COPD. Am J Respir Crit Care Med 2001, 163:122-128.
5. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med 2003, 167:544-549. 10.1164/rccm.200206-583OC, 12446268.
6. Martinez FJ, Foster G, Curtis JL, Criner G, Weinmann G, Fishman A, DeCamp MM, Benditt J, Sciurba F, Make B, Mohsenifar Z, Diaz P, Hoffman E, Wise R, . for the NETT Research Group Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 2006, 173:1326-1334. 10.1164/rccm.200510-1677OC, 2662972, 16543549, for the NETT Research Group.
7. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M. Longitudinal deteriorations in patient reported outcomes in patients with COPD. Respir Med 2007, 101:146-153. 10.1016/j.rmed.2006.04.001, 16713225.
8. Seemungal TAR, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 157:1418-1422.
9. Dourado VZ, Antunes LCO, Carvalho LR, Godoy I. Influência de características gerais na qualidade de vida em pacientes com doença pulmonar obstrutiva crônica. J Bras Pneumol 2004, 30:207-214.
10. Katsura H, Yamada K, Kida K. Both generic and disease specific health-related quality of life are deteriorated in patients with underweight COPD. Respir Med 2005, 99:624-630. 10.1016/j.rmed.2004.09.017, 15823461.
11. Lin YX, Xu WN, Liang LR, Pang BS, Nie XH, Zhang J, Wang H, Liu YX, Wang DQ, Xu ZY, Wang HW, Zhang HS, He ZY, Yang T, Wang C. The cross-sectional and longitudinal association of the BODE index with quality of life in patients with chronic obstructive pulmonary disease. Chin Med J (Engl) 2009, 122:2939-2944.
12. Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet 2007, 370:786-796. Review, 10.1016/S0140-6736(07)61382-8, 17765528.
13. Jardim JR, Oliveira JA, Nascimento O. II Consenso Brasileiro de DPOC. J Bras Pneumol 2004, 30(Suppl 5):1-42.
14. American Thoracic Society statement. Standardization of Spirometry-Update. Am Rev Respir Dis 1987, 136:1285-1298.
15. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the Normal Maximal Expiratory Flow-Volume Curve with Growth and Aging. Am Rev Respir Dis 1983, 127:725-734.
16. Sousa TC, Jardim JR, Jones P. Validation of the Saint George Respiratory Questionnaire (SGRQ) in patients with chronic obstructive disease in Brazil. J Bras Pneumol 2000, 26:119-125.
17. Jones PW. Interpreting thresholds for a clinically signifi{ligature}cant change in health status in asthma and COPD. Eur Respir J 2002, 19:398-404. 10.1183/09031936.02.00063702, 11936514.
18. Kovelis D, Segretti NO, Probst VS, Lareau SC, Brunetto AF, Pitta F. Validação do Modified Pulmonary Functional Status and Dyspnea Questionnaire e da escala do Medical Research Council para o uso em pacientes com doença pulmonar obstrutiva crônica no Brasil. J Bras Pneumol 2008, 34:1008-1018. 10.1590/S1806-37132008001200005, 19180335.
19. American Thoracic Society statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002, 166:111-117.
20. Celli BR, Cote CG, Marin JM, Casanova C. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004, 350:1005-1012. 10.1056/NEJMoa021322, 14999112.
21. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a Combined Comorbidity Index. J Clin Epidemiol 1994, 47:1245-1251. 10.1016/0895-4356(94)90129-5, 7722560.
22. Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest 2000, 117(Suppl 2):398-401.
23. Ferrari R, Tanni SE, Faganello MM, Caram LM, Lucheta PA, Godoy I. Three-year follow-up study of respiratory and systemic manifestations of chronic obstructive pulmonary disease. Braz J Med Biol Res 2011, 44:46-52. 10.1590/S0100-879X2010007500150, 21180880.
24. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Oga T. Stages of disease severity and factors that affect the health status of patients with chronic obstructive pulmonary disease. Respir Med 2000, 94:841-846. 10.1053/rmed.2000.0804, 11001074.
25. Antonelli-Incalzi R, Imperiale C, Bellia V, Catalano F, Scichilone N, Pistelli R, Rengo F, . SaRA Investigators Do GOLD stages of COPD severity really correspond to differences in health status?. Eur Respir J 2003, 22:444-449. 10.1183/09031936.03.00101203, 14516133, SaRA Investigators.
26. Ong KC, Lu SJ, Soh CS. Does the multidimensional grading system (BODE) correspond to differences in health status of patients with COPD?. Int J Chron Obstruct Pulmon Dis 2006, 1:91-96. 10.2147/copd.2006.1.1.91, 2706601, 18046907.
27. Medinas Amorós M, Mas-Tous C, Renom-Sotorra F, Rubí-Ponseti M, Centeno-Flores MJ, Gorriz-Dolz MT. Health-related quality of life is associated with COPD severity: a comparison between the GOLD staging and the BODE index. Chron Respir Dis 2009, 6:75-80. 10.1177/1479972308101551, 19411567.
28. Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea: contents, inter-observer agreement, and physiologic correlates of two new clinical indexes. Chest 1984, 85:751-758. 10.1378/chest.85.6.751, 6723384.
29. Schlecht NF, Schwartzman K, Bourbeau J. Dyspnea as clinical indicator in patients with chronic obstructive pulmonary disease. Chron Respir Dis 2005, 2:183-191. 10.1191/1479972305cd079oa, 16541601.
30. Spencer S, Calverley PM, Burge PS, Jones PW. Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J 2004, 23:698-702. 10.1183/09031936.04.00121404, 15176682.
31. Miravitlles M, Ferrer M, Pont A, Zalacain R, Alvarez-Sala JL, Masa F, Verea H, Murio C, Ros F, Vidal R, . IMPAC Study Group Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax 2004, 59:387-395. 10.1136/thx.2003.008730, 1746989, 15115864, IMPAC Study Group.
32. Cote CG, Dordelly LJ, Celli BR. Impact of COPD exacerbations on patient-centered outcomes. Chest 2007, 131:696-704. 10.1378/chest.06-1610, 17356082.
33. Ong KC, Earnest A, Lu SJ. A multidimensional grading system (BODE Index) as predictor for hospitalization for COPD. Chest 2005, 128:3810-3816. 10.1378/chest.128.6.3810, 16354849.
34. Casaburi R, Mahler DA, Jones PW, Wanner A, San PG, ZuWallack RL, Menjoge SS, Serby CW, Witek T. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 2002, 19:217-224. 10.1183/09031936.02.00269802, 11866001.
35. Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J, . TORCH investigators Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007, 356:775-789. 10.1056/NEJMoa063070, 17314337, TORCH investigators.
36. Fayers PM, Sprangers MAG. Understanding self rated health. Lancet 2002, 359:187-189. 10.1016/S0140-6736(02)07466-4, 11812551.
37. Farkas J, Hosnik M, Flezar M, Suskovic S, Lainscak M. Self-rated health predicts acute exacerbations and hospitalizations in patients with COPD. Chest 2010, 138:323-30. 10.1378/chest.09-2459, 20382715.
38. Nguyen HQ, Donesky-Cuenco D, Carrieri-Kohlman V. Associations between symptoms, functioning, and perceptions of mastery with global self-rated health in patients with COPD: a cross-sectional study. Int J Nurs Stud 2008, 45:1355-1365. 10.1016/j.ijnurstu.2007.09.012, 2651407, 17983617.
39. Farkas J, Kosnik M, Zaletel-Kragelj L, Flezar M, Suskovic S, Lainscak M. Distribution of self-rated health and association with clinical parameters in patients with chronic obstructive pulmonary disease. Wien Klin Wochenschr 2009, 121:297-302. 10.1007/s00508-009-1170-2, 19562290.
40. Katz P, Morris A, Gregorich S, Yazdany J, Eisner M, Yelin E, Blanc P. Valued life activity disability played a significant role in self-rated health among adults with chronic health conditions. J Clin Epidemiol 2009, 62:158-166. 10.1016/j.jclinepi.2008.06.002, 2633356, 18722089.
41. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 157:785-790.